The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-amino-5-(1-methyl-1H-imidazol-5-yl)-N7-(beta-D-ribofuranosyl)-pyrrolo[2,3-d]pyrimidine ID: ALA4448104
PubChem CID: 155519673
Max Phase: Preclinical
Molecular Formula: C15H18N6O4
Molecular Weight: 346.35
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: Cn1cncc1-c1cn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c2ncnc(N)c12
Standard InChI: InChI=1S/C15H18N6O4/c1-20-6-17-2-8(20)7-3-21(14-10(7)13(16)18-5-19-14)15-12(24)11(23)9(4-22)25-15/h2-3,5-6,9,11-12,15,22-24H,4H2,1H3,(H2,16,18,19)/t9-,11-,12-,15-/m1/s1
Standard InChI Key: RQRLWQIRZMRGAT-SDBHATRESA-N
Molfile:
RDKit 2D
25 28 0 0 0 0 0 0 0 0999 V2000
13.3144 -22.1467 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.5426 -22.4150 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5497 -21.3543 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3710 -21.3378 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3033 -23.2074 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8658 -21.9527 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.9831 -22.6131 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4819 -23.2239 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6434 -22.1137 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2096 -22.4521 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1205 -20.6568 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.7631 -20.6196 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3339 -19.9221 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.5125 -19.9386 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8027 -23.8554 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.5844 -20.5949 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.0114 -23.8925 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.4254 -22.2127 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7155 -22.6172 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.3492 -22.5223 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4379 -23.3329 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2354 -23.5034 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.6440 -22.7976 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0990 -22.1910 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.2705 -21.3920 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 1
3 1 1 0
4 3 2 0
5 2 1 0
6 2 1 0
7 1 1 0
8 5 1 0
9 7 2 0
10 6 1 0
11 3 1 0
12 4 1 0
13 14 1 0
14 11 2 0
5 15 1 6
16 12 1 0
8 17 1 6
10 18 1 1
9 4 1 0
10 8 1 0
12 13 2 0
18 19 1 0
9 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 20 1 0
24 25 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 346.35Molecular Weight (Monoisotopic): 346.1390AlogP: -0.97#Rotatable Bonds: 3Polar Surface Area: 144.47Molecular Species: NEUTRALHBA: 10HBD: 4#RO5 Violations: ┄HBA (Lipinski): 10HBD (Lipinski): 5#RO5 Violations (Lipinski): ┄CX Acidic pKa: 12.46CX Basic pKa: 6.73CX LogP: -1.61CX LogD: -1.66Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.47Np Likeness Score: 0.78
References 1. Hulpia F, Campagnaro GD, Scortichini M, Van Hecke K, Maes L, de Koning HP, Caljon G, Van Calenbergh S.. (2019) Revisiting tubercidin against kinetoplastid parasites: Aromatic substitutions at position 7 improve activity and reduce toxicity., 164 [PMID:30677668 ] [10.1016/j.ejmech.2018.12.050 ]